Ajanta Pharma Limited (AJANTPHARM.BO)
INR 2884.0
(-0.28%)
INR 2884.0
(-0.28%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 8.28 Billion INR | 1.56% |
| 2022 | 8.15 Billion INR | 3.1% |
| 2021 | 7.91 Billion INR | 3.21% |
| 2020 | 7.66 Billion INR | 54.63% |
| 2019 | 4.95 Billion INR | 13.76% |
| 2018 | 4.35 Billion INR | 24.26% |
| 2017 | 3.5 Billion INR | 66.16% |
| 2016 | 2.11 Billion INR | 3.15% |
| 2015 | 2.04 Billion INR | 28.64% |
| 2014 | 1.59 Billion INR | 2.34% |
| 2013 | 1.55 Billion INR | 5.28% |
| 2012 | 1.47 Billion INR | -12.04% |
| 2011 | 1.67 Billion INR | 48.34% |
| 2010 | 1.13 Billion INR | -5.44% |
| 2009 | 1.19 Billion INR | 15.14% |
| 2008 | 1.03 Billion INR | 11.99% |
| 2007 | 927.72 Million INR | 30.97% |
| 2006 | 708.35 Million INR | -2.13% |
| 2005 | 723.74 Million INR | 7.29% |
| 2004 | 674.56 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 8.45 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 8.28 Billion INR | 1.56% |
| 2023 Q4 | 8.28 Billion INR | 0.0% |
| 2023 Q2 | 7.85 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 7.48 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 8.15 Billion INR | 3.1% |
| 2022 Q4 | 8.15 Billion INR | 0.0% |
| 2021 Q4 | 7.91 Billion INR | 0.0% |
| 2021 FY | 7.91 Billion INR | 3.21% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 7.86 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 7.66 Billion INR | 0.0% |
| 2020 FY | 7.66 Billion INR | 54.63% |
| 2020 Q2 | 6.33 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 FY | 4.95 Billion INR | 13.76% |
| 2019 Q4 | 4.95 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 4.5 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 4 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 4.35 Billion INR | 24.26% |
| 2018 Q4 | 4.35 Billion INR | 0.0% |
| 2017 FY | 3.5 Billion INR | 66.16% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 2.64 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 3.5 Billion INR | 0.0% |
| 2016 Q4 | 2.11 Billion INR | 0.0% |
| 2016 FY | 2.11 Billion INR | 3.15% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 1.98 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 2.04 Billion INR | 28.64% |
| 2015 Q4 | 2.04 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 1.68 Billion INR | 0.0% |
| 2014 FY | 1.59 Billion INR | 2.34% |
| 2014 Q4 | 1.59 Billion INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 1.55 Billion INR | 5.28% |
| 2012 FY | 1.47 Billion INR | -12.04% |
| 2011 FY | 1.67 Billion INR | 48.34% |
| 2010 FY | 1.13 Billion INR | -5.44% |
| 2009 FY | 1.19 Billion INR | 15.14% |
| 2008 FY | 1.03 Billion INR | 11.99% |
| 2007 FY | 927.72 Million INR | 30.97% |
| 2006 FY | 708.35 Million INR | -2.13% |
| 2005 FY | 723.74 Million INR | 7.29% |
| 2004 FY | 674.56 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amrutanjan Health Care Limited | 289.04 Million INR | -2765.832% |
| Sigachi Industries Limited | 707.2 Million INR | -1071.312% |
| Bal Pharma Limited | 878.11 Million INR | -843.34% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -7821.053% |
| Medico Remedies Limited | 163.37 Million INR | -4970.391% |
| Lasa Supergenerics Limited | 190.43 Million INR | -4249.853% |
| Venus Remedies Limited | 1.21 Billion INR | -580.713% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -5961.777% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -16.81% |
| Shilpa Medicare Limited | 3.44 Billion INR | -140.154% |
| Aarti Drugs Limited | 4.85 Billion INR | -70.483% |
| Lupin Limited | 49.53 Billion INR | 83.279% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 91.554% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 75.933% |
| Windlas Biotech Limited | 621.89 Million INR | -1232.004% |
| Suven Life Sciences Limited | 7.08 Million INR | -116817.431% |
| Eris Lifesciences Limited | 1.89 Billion INR | -338.212% |
| Valiant Laboratories Limited | 100.15 Million INR | -8170.863% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -64.844% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -130.292% |
| Ipca Laboratories Limited | 24.71 Billion INR | 66.481% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -599.349% |
| Achyut Healthcare Limited | 568 Thousand INR | -1458280.282% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 91.606% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -475.097% |
| RPG Life Sciences Limited | 1.01 Billion INR | -720.158% |
| Mankind Pharma Limited | 15.53 Billion INR | 46.676% |
| Laurus Labs Limited | 18.45 Billion INR | 55.112% |
| Piramal Pharma Limited | 21.75 Billion INR | 61.93% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -3829.322% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 63.652% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 49.599% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 67.038% |
| Unichem Laboratories Limited | 7.04 Billion INR | -17.552% |
| Sequent Scientific Limited | 3.46 Billion INR | -139.25% |
| Novartis India Limited | 448.6 Million INR | -1746.545% |
| Wanbury Limited | 360.23 Million INR | -2199.518% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -258.294% |
| Wockhardt Limited | 6.4 Billion INR | -29.431% |
| Themis Medicare Limited | 705.74 Million INR | -1073.742% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -5423.505% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 35.766% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -24.268% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 86.966% |
| Divi's Laboratories Limited | 31.84 Billion INR | 73.984% |
| NATCO Pharma Limited | 7 Billion INR | -18.253% |
| Gufic Biosciences Limited | 2 Billion INR | -313.184% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -94.982% |
| Ind-Swift Limited | 640.91 Million INR | -1192.465% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -659.197% |
| FDC Limited | 3.88 Billion INR | -113.007% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -8355.759% |
| Granules India Limited | 13 Billion INR | 36.307% |
| Medicamen Biotech Limited | 593.75 Million INR | -1295.128% |
| Alkem Laboratories Limited | 26.61 Billion INR | 68.872% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -263.504% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -32388.528% |
| Brooks Laboratories Limited | 96.1 Million INR | -8519.054% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -919.358% |
| Strides Pharma Science Limited | 11.26 Billion INR | 26.449% |
| Neuland Laboratories Limited | 3.5 Billion INR | -136.389% |
| Morepen Laboratories Limited | 2.48 Billion INR | -233.218% |
| Hikal Limited | 3.03 Billion INR | -172.738% |
| Indoco Remedies Limited | 3.53 Billion INR | -134.623% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -28.855% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -20671.314% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -569.978% |
| Hester Biosciences Limited | 755.81 Million INR | -995.99% |